Edesa Biotech, Inc. — Director's Dealing 2016

Dec 13, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2016-12-08

Reporting Person: Olson Charles V (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Share Option (Right to Buy)	$15.20	2021-11-12	Common Shares (1250)		Direct

Footnotes

F1: The option was granted by the Issuer to the Reporting Person, in connection with the Reporting Person's service on the Issuer's Scientific Advisory Board, on November 12, 2014. The option is fully vested and immediately exercisable.